Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Ambinder

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
International Journal of Cancer|February 7, 1997
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international dataS L Glaser, R J Lin, S L Stewart, et al.
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
International Journal of Cancer|February 7, 1997
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international dataS L Glaser, R J Lin, S L Stewart, et al.
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Pageof 11